These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 19840363
21. Modulation by heparin of the interaction of the A1 domain of Von Willebrand factor with glycoprotein Ib. Perrault C, Ajzenberg N, Legendre P, Rastegar-Lari G, Meyer D, Lopez JA, Baruch D. Blood; 1999 Dec 15; 94(12):4186-94. PubMed ID: 10590063 [Abstract] [Full Text] [Related]
22. Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ibalpha shedding. Cheng H, Yan R, Li S, Yuan Y, Liu J, Ruan C, Dai K. Am J Physiol Heart Circ Physiol; 2009 Dec 15; 297(6):H2128-35. PubMed ID: 19820200 [Abstract] [Full Text] [Related]
23. Phenotype changes resulting in high-affinity binding of von Willebrand factor to recombinant glycoprotein Ib-IX: analysis of the platelet-type von Willebrand disease mutations. Tait AS, Cranmer SL, Jackson SP, Dawes IW, Chong BH. Blood; 2001 Sep 15; 98(6):1812-8. PubMed ID: 11535515 [Abstract] [Full Text] [Related]
24. Regulation of glycoprotein Ib-IX-von Willebrand factor interaction by cAMP-dependent protein kinase-mediated phosphorylation at Ser 166 of glycoprotein Ib(beta). Bodnar RJ, Xi X, Li Z, Berndt MC, Du X. J Biol Chem; 2002 Dec 06; 277(49):47080-7. PubMed ID: 12361948 [Abstract] [Full Text] [Related]
25. GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events. Gardiner EE, Arthur JF, Shen Y, Karunakaran D, Moore LA, Am Esch JS, Andrews RK, Berndt MC. Platelets; 2010 Dec 06; 21(4):244-52. PubMed ID: 20367574 [Abstract] [Full Text] [Related]
26. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha. Cauwenberghs N, Vanhoorelbeke K, Vauterin S, Westra DF, Romo G, Huizinga EG, Lopez JA, Berndt MC, Harsfalvi J, Deckmyn H. Blood; 2001 Aug 01; 98(3):652-60. PubMed ID: 11468163 [Abstract] [Full Text] [Related]
29. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. Yago T, Lou J, Wu T, Yang J, Miner JJ, Coburn L, López JA, Cruz MA, Dong JF, McIntire LV, McEver RP, Zhu C. J Clin Invest; 2008 Sep 01; 118(9):3195-207. PubMed ID: 18725999 [Abstract] [Full Text] [Related]
30. Identification of a small molecule that modulates platelet glycoprotein Ib-von Willebrand factor interaction. Broos K, Trekels M, Jose RA, Demeulemeester J, Vandenbulcke A, Vandeputte N, Venken T, Egle B, De Borggraeve WM, Deckmyn H, De Maeyer M. J Biol Chem; 2012 Mar 16; 287(12):9461-72. PubMed ID: 22232560 [Abstract] [Full Text] [Related]
31. Destabilization of the A1 domain in von Willebrand factor dissociates the A1A2A3 tri-domain and provokes spontaneous binding to glycoprotein Ibalpha and platelet activation under shear stress. Auton M, Sowa KE, Smith SM, Sedlák E, Vijayan KV, Cruz MA. J Biol Chem; 2010 Jul 23; 285(30):22831-9. PubMed ID: 20498367 [Abstract] [Full Text] [Related]
32. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα. Ju L, Dong JF, Cruz MA, Zhu C. J Biol Chem; 2013 Nov 08; 288(45):32289-32301. PubMed ID: 24062306 [Abstract] [Full Text] [Related]
33. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion. Miura S, Li CQ, Cao Z, Wang H, Wardell MR, Sadler JE. J Biol Chem; 2000 Mar 17; 275(11):7539-46. PubMed ID: 10713059 [Abstract] [Full Text] [Related]
34. Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val. Doggett TA, Girdhar G, Lawshe A, Miller JL, Laurenzi IJ, Diamond SL, Diacovo TG. Blood; 2003 Jul 01; 102(1):152-60. PubMed ID: 12637314 [Abstract] [Full Text] [Related]
36. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions. Dong JF, Berndt MC, Schade A, McIntire LV, Andrews RK, López JA. Blood; 2001 Jan 01; 97(1):162-8. PubMed ID: 11133756 [Abstract] [Full Text] [Related]
37. Dual roles of fucoidan-GPIbα interaction in thrombosis and hemostasis: implications for drug development targeting GPIbα. Shen C, Mackeigan DT, Shoara AA, Xu R, Bhoria P, Karakas D, Ma W, Cerenzia E, Chen Z, Hoard B, Lin L, Lei X, Zhu G, Chen P, Johnson PE, Ni H. J Thromb Haemost; 2023 May 01; 21(5):1274-1288. PubMed ID: 36732162 [Abstract] [Full Text] [Related]
38. Human signaling protein 14-3-3zeta interacts with platelet glycoprotein Ib subunits Ibalpha and Ibbeta. Calverley DC, Kavanagh TJ, Roth GJ. Blood; 1998 Feb 15; 91(4):1295-303. PubMed ID: 9454760 [Abstract] [Full Text] [Related]
39. Platelets with a W127X mutation in GPIX express sufficient residual amounts of GPIbα to support adhesion to von Willebrand factor and collagen. Takata Y, Kanaji T, Moroi M, Seki R, Sano M, Nakazato S, Sueoka E, Imamura Y, Okamura T. Int J Hematol; 2012 Dec 15; 96(6):733-42. PubMed ID: 23143686 [Abstract] [Full Text] [Related]
40. Platelet glycoprotein Ib beta/IX mediates glycoprotein Ib alpha localization to membrane lipid domain critical for von Willebrand factor interaction at high shear. Geng H, Xu G, Ran Y, López JA, Peng Y. J Biol Chem; 2011 Jun 17; 286(24):21315-23. PubMed ID: 21507943 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]